# Assessment of VMCore Biopsy Versus Standard of Care Biopsy

> **NCT04982536** · NA · UNKNOWN · sponsor: **Uro-1 Medical** · enrollment: 40 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** VMCore Biopsy System
- **DEVICE:** Standard of Care Biopsy Needle

## Key facts

- **NCT ID:** NCT04982536
- **Lead sponsor:** Uro-1 Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-19
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04982536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04982536, "Assessment of VMCore Biopsy Versus Standard of Care Biopsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04982536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*